🚨 new paper alert 🚨
Here we apply our protein nanoparticle vaccine platform toward a bacterial indication: uropathogenic E. coli, the primary causative agent of UTIs:
bit.ly/4waDqaM
bit.ly
Frontiers | Improving the immunogenicity of E. coli FimH via multivalent display on I53-50 nanoparticles
Urinary tract infections, caused primarily by uropathogenic E. coli, are a significant public health burden, affecting approximately 50% of women worldwide. ...